Predictive Value of Transabdominal Intestine Sonography in Critically Ill Patients

July 4, 2018 updated by: Gao Tao, Nanjing PLA General Hospital

Predictive Value of Transabdominal Intestine Sonography in Critically Ill Patients:A Prospective, Observational Study

It is very important to evaluate the degree of gastrointestinal dysfunction in critical ill patients. Thus the investigators conducted transabdominal intestine ultrasonography(US) in critical ill patients to evaluated the degree of gastrointestinal dysfunction under the acute gastrointestinal injury (AGI)

Study Overview

Study Type

Observational

Enrollment (Actual)

136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients with severe complications after surgery and severe trauma

Description

Inclusion Criteria:

  • aged more than 18 years
  • Acute Physiology Chronic Health Evaluation II (APACHE II) score >8

Exclusion Criteria:

  • uncontrolled mesenteric vascular disease
  • uncontrolled chronic organ dysfunction
  • advanced cancer
  • any terminal stage disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
GIF score
assess the AGI by gastrointestinal failure(GIF) score
assessment by GIF score
assessment by ultrasonography score
US score
assess the AGI by ultrasonography(US) score
assessment by GIF score
assessment by ultrasonography score

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
predict value of 28-day mortality
Time Frame: one and a half year
predict value of 28-day mortality
one and a half year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2016

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

April 1, 2018

Study Registration Dates

First Submitted

June 23, 2018

First Submitted That Met QC Criteria

July 4, 2018

First Posted (Actual)

July 17, 2018

Study Record Updates

Last Update Posted (Actual)

July 17, 2018

Last Update Submitted That Met QC Criteria

July 4, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2016NLYZDRC015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on GIF score

3
Subscribe